Literature DB >> 22083665

The use of N-methylpyrrolidone as a cosolvent and oxidant in pharmaceutical stress testing.

Dan W Reynolds1, Marina Galvani, Simon R Hicks, Biren J Joshi, Sonya A Kennedy-Gabb, Mark H Kleinman, Paresh Z Parmar.   

Abstract

The use of N-methylpyrrolidone (NMP) as an oxidant and cosolvent in pharmaceutical stress testing (forced degradation) is examined. Various active pharmaceutical ingredients were heated in NMP-water solutions under nitrogen, air, and oxygen and then analyzed by high-performance liquid chromatography, usually with ultraviolet diode array detection and mass spectrometry detection. In some cases, degradation products were isolated and characterized by nuclear magnetic resonance. The NMP-water-air-heat system provided oxidative and hydrolytic degradation products. The observed oxidation products were consistent with products expected from free radical autoxidation, reactions with hydroperoxides, and possibly singlet oxygen. Oxidative and hydrolytic pathways could be distinguished by comparison of the reactions carried out under air/oxygen and nitrogen. In many cases, the oxidation products observed during stress testing were also observed during formal stability studies of drug products. The NMP-water-air-heat stress condition facilitates various oxidative degradation pathways, which are often relevant to drug product on stability. This approach facilitates stability-indicating method development and helps elucidate degradation pathways.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22083665     DOI: 10.1002/jps.22793

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  3 in total

1.  Recent trends in product development and regulatory issues on impurities in active pharmaceutical ingredient (API) and drug products. Part 1: Predicting degradation related impurities and impurity considerations for pharmaceutical dosage forms.

Authors:  Karen M Alsante; Kim Huynh-Ba; Steven W Baertschi; Robert A Reed; Margaret S Landis; Mark H Kleinman; Christopher Foti; Venkatramana M Rao; Paul Meers; Andreas Abend; Daniel W Reynolds; Biren K Joshi
Journal:  AAPS PharmSciTech       Date:  2013-11-27       Impact factor: 3.246

2.  PVP-H2O2 Complex as a New Stressor for the Accelerated Oxidation Study of Pharmaceutical Solids.

Authors:  Dattatray Modhave; Brenda Barrios; Amrit Paudel
Journal:  Pharmaceutics       Date:  2019-09-03       Impact factor: 6.321

3.  Influence of Organic Solvents on Secondary Brain Damage after Experimental Traumatic Brain Injury.

Authors:  Johannes Walter; Julian Schwarting; Nikolaus Plesnila; Nicole A Terpolilli
Journal:  Neurotrauma Rep       Date:  2020-11-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.